Filana Therapeutics (FLNA) Receivables - Other (2011 - 2026)
Filana Therapeutics (FLNA) posted quarterly Receivables - Other of $117000.0 for Q1 2026, down 86.46% year-over-year from $864000.0 in Q1 2025, and down 2.5% quarter-over-quarter from $120000.0 in Q4 2025.
Filana Therapeutics (FLNA) Receivables - Other (2011 - 2026) Analysis & Trends
Filana Therapeutics' Receivables - Other history runs 8 years deep, the most recent figure standing at $117000.0 for Q1 2026.
- In Q1 2026, Receivables - Other fell 86.46% year-over-year to $117000.0; the TTM figure through Mar 2026 stood at $117000.0 (down 86.46% YoY), while the FY2025 annual figure was $120000.0, down 87.33% from the prior year.
- Receivables - Other for Q1 2026 stood at $117000.0, down from $120000.0 in the prior quarter.
- The five-year high for Receivables - Other was $5.0 million in Q3 2024, with the low at $117000.0 in Q1 2026.
- The 4-year median for Receivables - Other is $954500.0 (2023), against an average of $1.2 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 289.11% in 2024, then sank 87.33% in 2025.
- Filana Therapeutics' Receivables - Other stood at $962000.0 in 2023, then retreated by 1.56% to $947000.0 in 2024, then tumbled by 87.33% to $120000.0 in 2025, then retreated by 2.5% to $117000.0 in 2026.
- Business Quant data shows FLNA's Receivables - Other at $117000.0 in Q1 2026, $120000.0 in Q4 2025, and $817000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Filana Therapeutics | 46.20 Mn | 46.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Jun 30, 2025 | 835,000.00 |
| Jun 30, 2025 | 835,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 947,000.00 |
| Dec 31, 2024 | 947,000.00 |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 962,000.00 |
| Dec 31, 2023 | 962,000.00 |